Membrane fluidity alteration

Membrane fluidity alteration is not a specific molecular target but rather a physical property of lipid bilayers reflecting how freely lipid and protein components of biological membranes can move within the membrane plane. Membrane fluidity affects essential biological processes including protein mobility, signaling, and membrane permeability. It is influenced by lipid composition (such as the balance of saturated vs. unsaturated fatty acids, cholesterol content), temperature, and interactions with membrane proteins[3][4][5]. Substantial changes to membrane fluidity can phase-separate lipids, scatter or cluster membrane proteins, and severely disrupt vital cellular processes such as cytokinesis, cell wall synthesis, and energy maintenance[2][3][6]. Key caveat: "Membrane fluidity alteration" is a **property or a process, not a discrete molecular entity or therapeutic target**—no drug acts directly and specifically on “membrane fluidity alteration” as a target in the sense of a receptor, enzyme, or protein[2][3][5]. The entries above reflect this, and underscore a need to reference specific membrane components or proteins for target-based drug discovery or therapeutic intervention.

Other names

Membrane fluidity modulationMembrane fluidity change

Compounds may increase or decrease membrane fluidity by: - Altering lipid composition (e.g., increased unsaturated fatty acids increase fluidity) - Incorporating cholesterol (which buffers fluidity and stabilizes the membrane) - Modifying temperature or environmental conditions[4][5].